Leptospirosis is an acute febrile disease with varied manifestations characterized by vasculitis. The severity of disease ranges from asymptomatic or subclinical to self-limited systemic illness (approximately 90% of patients) to life-threatening illness with jaundice, renal failure, and hemorrhagic pneumonitis. The clinical presentation typically is biphasic, with an acute septicemia phase usually lasting 1 week, which is followed by a second immune-mediated phase. Regardless of its severity, the acute phase is characterized by nonspecific symptoms, including fever, chills, headache, nausea, vomiting, and a transient rash. The most distinct clinical findings are conjunctival suffusion without purulent discharge (30%-99% of cases) and myalgias of the calf and lumbar regions (40% to 100% of cases). In some patients, the 2 phases are separated by a short-lived abatement of fever (3-4 days). Findings commonly associated with the immune-mediated phase include fever, aseptic meningitis, conjunctival suffusion, uveitis, muscle tenderness, adenopathy, and purpuric rash. Approximately 10% of patients have severe illness, including jaundice and renal dysfunction (Weil syndrome), hemorrhagic pneumonitis, cardiac arrhythmias, or circulatory collapse associated with a case-fatality rate of 5% to 15%. The overall duration of symptoms for both phases of disease varies from less than 1 week to several months. Asymptomatic or subclinical infection is frequent, and seroconversion can occur, especially in settings of endemic infection.
Leptospirosis has been found in Red Book 28e
If you are a registered user, please login below.